580 results on '"Davis, Corey S."'
Search Results
2. Legal Epidemiology in Post-Prohibition Scenarios
3. Investigating the complexity of naloxone distribution: Which policies matter for pharmacies and potential recipients
4. Drug-related physician continuing medical education requirements, 2010–2020
5. When effects cannot be estimated: redefining estimands to understand the effects of naloxone access laws
6. Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care
7. Good Samaritan laws and overdose mortality in the United States in the fentanyl era
8. Effects of Opioid Prescribing Cap Laws on Opioid and Other Pain Treatments Among Persons with Chronic Pain
9. Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington
10. Typology of laws restricting access to methadone treatment in the United States: A latent class analysis
11. Pathways to racial disparities in the effects of Good Samaritan Laws: A mixed methods pilot study
12. National survey findings on law enforcement agency drug response practices, overdose victim outcomes, and Good Samaritan Laws
13. Effects of state opioid prescribing cap laws on providers' opioid prescribing patterns among patients with chronic non-cancer pain
14. Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states
15. Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses.
16. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
17. Effects of state opioid prescribing cap laws on opioid prescribing after surgery
18. Principles and Metrics for Evaluating Oregon’s Innovative Drug Decriminalization Measure
19. Genetic management on the brink of extinction: sequencing microsatellites does not improve estimates of inbreeding in wild and captive Vancouver Island marmots (Marmota vancouverensis)
20. A modified Delphi process to identify experts’ perceptions of the most beneficial and harmful laws to reduce opioid-related harm
21. Evaluation of novel genomic markers for pedigree construction in an isolated population of Weddell Seals (Leptonychotes weddellii) at White Island, Antarctica
22. Yes, You Need a Lawyer : Integrating Legal Epidemiology Into Health Research
23. Declining but Pronounced State-Level Disparities in Prescription Opioid Distribution in the United States
24. Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19
25. Harm Reduction, By Mail: the Next Step in Promoting the Health of People Who Use Drugs
26. When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws
27. Environmental DNA in lake sediment reveals biogeography of native genetic diversity
28. Association between medical cannabis laws and opioid overdose mortality has reversed over time
29. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
30. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review
31. Opioid-overdose laws association with opioid use and overdose mortality
32. One-Year Association of Drug Possession Law Change With Fatal Drug Overdose in Oregon and Washington
33. Reducing Harm Through Litigation Against Opioid Manufacturers? Lessons From the Tobacco Wars
34. Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid
35. State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies
36. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States
37. Management implications of highly resolved hierarchical population genetic structure in thinhorn sheep
38. Prescription drug monitoring program design and function: A qualitative analysis
39. Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
40. A discussion of critical errors in a longitudinal study on the deterrent effect of drug‐induced homicide laws on opioid‐related mortality across 92 counties and the District of Columbia in the United States
41. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019
42. Today’s fentanyl crisis: Prohibition’s Iron Law, revisited
43. Molecular Evidence for Twinning in Weddell Seals (Leptonychotes weddellii)
44. Opioid Policy Changes During the COVID-19 Pandemic - and Beyond
45. Evidence of an Absence of Inbreeding Depression in a Wild Population of Weddell Seals (Leptonychotes weddellii)
46. Persistent Criminalization and Structural Racism in US Drug Policy: The Case of Overdose Good Samaritan Laws
47. Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements
48. Legal changes to increase access to naloxone for opioid overdose reversal in the United States
49. Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients.
50. Declines and pronounced state level disparities in prescription opioid distribution in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.